The Current Ratio as of January 2026 (TTM) for MapLight Therapeutics, Inc. (MPLT) is 13.22

According to MapLight Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 13.22. This represents a change of 60.83% compared to the average of 8.22 of the last 4 quarters.

MapLight Therapeutics, Inc. (MPLT) Historical Current Ratio (quarterly & annually)

How has MPLT Current Ratio performed in the past?

The mean historical Current Ratio of MapLight Therapeutics, Inc. over the last ten years is 5.14. The current 13.22 Current Ratio has changed 25.59% with respect to the historical average. Over the past ten years (40 quarters), MPLT's Current Ratio was at its highest in in the September 2025 quarter at 13.22. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

MapLight Therapeutics, Inc. (MPLT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of MapLight Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MapLight Therapeutics, Inc. (MPLT) Average Current Ratio

How has MPLT Current Ratio performed in the past?

The current Current Ratio of MapLight Therapeutics, Inc. (MPLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MapLight Therapeutics, Inc. (MPLT) Current Ratio vs. Peers

How is MPLT’s Current Ratio compared to its peers?

MapLight Therapeutics, Inc.’s Current Ratio is greater than ProMIS Neurosciences, Inc. (1.76), greater than Edesa Biotech, Inc. (10.67), greater than Ernexa Therapeutics Inc. (1.58), greater than BiomX Inc. (1.70), greater than BioRestorative Therapies, Inc. (1.37), greater than Immuron Limited (5.09), greater than Dogwood Therapeutics, Inc. (4.49), greater than Lipocine Inc. (8.25), greater than Traws Pharma, Inc. (2.09), greater than OSR Holdings, Inc. (0.21),

Build a custom stock screener for MapLight Therapeutics, Inc. (MPLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MapLight Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MapLight Therapeutics, Inc. (MPLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MapLight Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.